Arkolith/Insider Trading/NKGN/Form 4

Graf Acquisition Partners IV LLC

10% OwnerNKGen Biotech, Inc. (NKGN) · full profile →Form 4 · filed Nov 22, 2023
Net Buying
Open-Market Buys
$67
Open-Market Sells
$0
Net Open-Market Flow
$67
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 21, 2023Buy(P)13$2.92$3823
Nov 20, 2023Buy(P)10$2.94$2910

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-056524) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML